Neurogene Inc. 4

Insider Keith Woods received a fully vested non-qualified stock option award for 12,050 Neurogene Inc. shares at a $20.40 exercise price.

On June 12, 2025, Neurogene Inc. insider Keith Woods received a fully vested non-qualified stock option award covering 12,050 shares of common stock at an exercise price of $20.40 per share, with an expiration date of June 12, 2035. This derivative grant, reported as an acquisition, resulted in Woods holding derivative rights to purchase 12,050 shares and a corresponding beneficial ownership of 12,050 shares of common stock reported as directly owned after the transaction. The Form 4 is filed as an amendment solely to correct the reporting person's CIK number and otherwise replaces the original filing in its entirety, indicating this is a routine equity compensation grant rather than an open-market transaction.

Filing Facts

CIK

1404644

Ticker

NGNE

Form

4

Source Type

sec

Accession

0001996804-26-000009

Alert Tier

5